Physician profile
Lawrence Weidell
NPI 1770540122
$1,967.73
in general payments reported to CMS, 2019-2025
15 companies · $99.96 in 2025
The $99.96 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $869 · 2022: $621 · 2023: $98.00 · 2024: $280 · 2025: $99.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.76 |
| Education | $194.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $254.39 | 2021-2022 | |
| Genzyme Corporation | $249.50 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $248.84 | 2021-2024 | Libtayo |
| Sun Pharmaceutical Industries INC. | $232.13 | 2021-2025 | |
| Janssen Biotech, INC. | $227.00 | 2021-2024 | Tremfya |
| Lilly USA, LLC | $135.72 | 2021-2023 | Olumiant, Taltz |
| Novartis Pharmaceuticals Corporation | $127.45 | 2021-2023 | |
| Amgen INC. | $117.49 | 2021-2022 | |
| Pfizer INC. | $100.57 | 2021-2024 | |
| Leo Pharma INC. | $92.14 | 2021-2023 | Adbry |
| Sanofi-Aventis U.S. LLC | $65.37 | 2022 | |
| Ucb, INC. | $41.79 | 2021 | |
| Incyte Corporation | $28.78 | 2021-2022 | |
| Galderma Laboratories, L.P. | $27.44 | 2021-2022 | |
| Organon LLC | $19.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Weidell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.